Severe presentation of Beckwith–Wiedemann syndrome associated with high levels of constitutional paternal uniparental disomy for chromosome 11p15

Beckwith–Wiedemann syndrome (BWS) is an overgrowth syndrome characterized by macrosomia, macroglossia, omphalocele, hemihyperplasia, and increased tumor risk. BWS can be associated with genetic and/or epigenetic alterations that modify imprinted gene expression on chromosome 11p15.5. Somatic mosaicism for paternal uniparental disomy (UPD) of chromosome 11p15, found in 20% of BWS patients, is associated with specific features of BWS including hemihyperplasia, Wilms tumor, and hepatoblastoma. The highly variable phenotypic spectrum of BWS associated with UPD may well reflect the level of UPD 11 cells in specific organs and tissues such that very high levels of UPD might produce a more severe phenotypic expression of BWS. In this regard we report on two patients with severe presentations of BWS and extremely high levels of UPD in DNA from lymphocytes. Clinically, both patients demonstrated extreme macroglossia, persistent hypoglycemia, cardiomyopathy, hemihyperplasia, renal abnormalities, abdominal organomegaly, hepatoblastoma and died in the first 6 months of life. These two patients support the hypothesis that high levels of UPD define high expressivity in BWS. © 2007 Wiley‐Liss, Inc.

[1]  R. Curley,et al.  Mitotic recombination and uniparental disomy in Beckwith-Wiedemann syndrome. , 2007, Genomics.

[2]  E. Zackai,et al.  Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies , 2006, American journal of medical genetics. Part A.

[3]  W. Reik,et al.  Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndrome , 2005, European Journal of Human Genetics.

[4]  W. Reik,et al.  The two-domain hypothesis in Beckwith-Wiedemann syndrome: autonomous imprinting of the telomeric domain of the distal chromosome 7 cluster. , 2005, Human molecular genetics.

[5]  Jan Bressler,et al.  Epigenetics and human disease. , 2004, Annual review of genomics and human genetics.

[6]  C. Junien,et al.  Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome , 2003, Journal of medical genetics.

[7]  Rosanna Weksberg,et al.  Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. , 2003, Human molecular genetics.

[8]  W. Reik,et al.  Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions. , 2003, Human molecular genetics.

[9]  R. Weksberg,et al.  Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome. , 2002, Human molecular genetics.

[10]  K. Zerres,et al.  Uniparental disomy: clinical indications for testing in growth retardation , 2002, European Journal of Pediatrics.

[11]  S. Albrecht,et al.  Prognostic impact of molecular genetic alterations in hepatoblastoma. , 2002, Medical and pediatric oncology.

[12]  R. Weksberg,et al.  Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. , 2001, Human molecular genetics.

[13]  J. Ruijter,et al.  Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. , 2001, Human molecular genetics.

[14]  Shirley M. Tilghman,et al.  CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus , 2000, Nature.

[15]  A. Reeve,et al.  Proportion of cells with paternal 11p15 uniparental disomy correlates with organ enlargement in Wiedemann-beckwith syndrome. , 2000, American journal of medical genetics.

[16]  R. Nicholls The impact of genomic imprinting for neurobehavioral and developmental disorders. , 2000, The Journal of clinical investigation.

[17]  W. Reik,et al.  Beckwith-Wiedemann syndrome: imprinting in clusters revisited. , 2000, The Journal of clinical investigation.

[18]  A. Wolffe,et al.  Epigenetics: regulation through repression. , 1999, Science.

[19]  D. J. Driscoll,et al.  A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Fukushima,et al.  An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome , 1996, Nature Genetics.

[21]  C. Junien,et al.  Somatic Mosaicism for Partial Paternal Isodisomy in Wiedemann-Beckwith Syndrome: A Post-Fertilization Event , 1993, European journal of human genetics : EJHG.

[22]  C. Junien,et al.  Uniparental paternal disomy in a genetic cancer-predisposing syndrome , 1991, Nature.

[23]  Nan Faion T. Wu,et al.  The Beckwith-Wiedemann Syndrome , 1974, Clinical pediatrics.

[24]  J. Beckwith Macroglossia, omphalocele, adrenal cytomegaly, gigantism, and hyperplastic visceromegaly , 1969 .